Showing results (61-70 of 231) with videos related to

Sort By:
Pageof 24
Diabetes, Obesity & Metabolism|January 30, 2018
Two-year trial of intermittent insulin therapy vs metformin for the preservation of β-cell function after initial short-term intensive insulin induction in early type 2 diabetesRavi Retnakaran, Haysook Choi, Chang Ye, et al.
Nature Communications|October 16, 2022
The metabolic effects of adding exenatide to basal insulin therapy when targeting remission in early type 2 diabetes in a randomized clinical trialRavi Retnakaran, Chang Ye, Alexandra Emery, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 18, 2023
Gestational diabetes: One size does not fit all-an observational study of maternal and neonatal outcomes by maternal glucose profileRoseanne O Yeung, Ravi Retnakaran, Anamaria Savu, et al.
The Journal of Clinical Endocrinology and Metabolism|December 18, 2023
Contemporary Clinical Perspectives on Targeting Remission of Type 2 DiabetesRavi Retnakaran, Sangeeta R Kashyap, Hertzel C Gerstein, et al.
Diabetes Care|June 29, 2011
Changes over time in glycemic control, insulin sensitivity, and beta-cell function in response to low-dose metformin and thiazolidinedione combination therapy in patients with impaired glucose toleranceRavi Retnakaran, Ying Qi, Stewart B Harris, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 2015
The Impact of Chronic Liraglutide Therapy on Glucagon Secretion in Type 2 Diabetes: Insight From the LIBRA TrialCaroline K Kramer, Bernard Zinman, Haysook Choi, et al.
Diabetes, Obesity & Metabolism|February 10, 2017
Chronic liraglutide therapy induces an enhanced endogenous glucagon-like peptide-1 secretory response in early type 2 diabetesCaroline K Kramer, Bernard Zinman, Haysook Choi, et al.
The Journal of Clinical Endocrinology and Metabolism|August 19, 2007
Total and high molecular weight but not trimeric or hexameric forms of adiponectin correlate with markers of the metabolic syndrome and liver injury in Thai subjectsYing Liu, Ravi Retnakaran, Anthony Hanley, et al.
The Journal of Clinical Endocrinology and Metabolism|May 5, 2017
Impact of the Glucagon Assay When Assessing the Effect of Chronic Liraglutide Therapy on Glucagon SecretionCaroline K Kramer, Bernard Zinman, Haysook Choi, et al.
Diabetes, Obesity & Metabolism|September 18, 2025
Empagliflozin for the preservation of beta-cell function in women with recent gestational diabetes: A randomized placebo-controlled trialShamini Murugavel, Ravi Retnakaran, Denice S Feig, et al.
Pageof 24